Cost of Hepatitis C Antivirals May Keep Patients Away Tops SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. Toxic Components of Fire Ant Venom Reduce Inflammation in Psoriasis

Findings may lead to future treatments for patients with psoriasis and psoriatic arthritis. Read more…

4. First Predictive Model of Inflammatory Bowel Disease Developed

Study findings could lead to new treatment options for patients with IBD in the future. Read more…

3. Poor Adherence to Hormone Therapy Observed in Breast Cancer Survivors Taking Opioids

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects. Read more…

2. Repurposing Drugs for Cancer Treatment

Many researchers are interested in looking at FDA-approved drugs that could potentially be repositioned for use in cancer treatment. Read more…

1. Cost of Hepatitis C Antivirals May Keep Patients Away

Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals. Read more…

Related Videos
A panel of 4 experts
A panel of 4 experts
pharmacy oncology, Image Credit: © Konstantin Yuganov -
Video 6 - "evaluating CDK4/6 inhibitor safety profiles"
Video 5 - "CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC"
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Mayo Clinic oncology pharmacy
© 2024 MJH Life Sciences

All rights reserved.